` Comparison: 3902 vs 0R00 - Alpha Spread

3902
vs
C
0R00

Over the past 12 months, Medical Data Vision Co Ltd has significantly outperformed 0R00, delivering a return of +304% compared to the 0R00's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
3902
0R00
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

Intrinsic Value
500.12 JPY
Overvaluation 70%
Intrinsic Value
Price
C
0R00 Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Medical Data Vision Co Ltd
TSE:3902
1 683 JPY
C
Cerner Corp
LSE:0R00
94.985 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
3902, 0R00

3902
0R00
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Medical Data Vision Co Ltd
Revenue
C
Cerner Corp
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
3902, 0R00

3902
0R00
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Medical Data Vision Co Ltd
TSE:3902
C
Cerner Corp
LSE:0R00
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

Medical Data Vision Co Ltd
69.6%
0R00
82.5%

Operating Margin

Medical Data Vision Co Ltd
5.3%
0R00
12.8%

Net Margin

Medical Data Vision Co Ltd
4.3%
0R00
10.2%

FCF Margin

Medical Data Vision Co Ltd
11%
0R00
19.5%

ROE

Medical Data Vision Co Ltd
9.1%
0R00
14.3%

ROA

Medical Data Vision Co Ltd
5.9%
0R00
7.7%

ROIC

Medical Data Vision Co Ltd
49%
0R00
9.7%

ROCE

Medical Data Vision Co Ltd
10.6%
0R00
11.9%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
3902, 0R00

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
3902, 0R00

Loading
3902
0R00
Difference
www.alphaspread.com

Performance By Year
3902, 0R00

Loading
3902
0R00
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 3902 to other stocks
VEEV
Veeva Systems Inc
Cheaper
vs Medical Data Vision Co Ltd
PME
Pro Medicus Ltd
More expensive
vs Medical Data Vision Co Ltd
2413
M3 Inc
Cheaper
vs Medical Data Vision Co Ltd
WAY
Waystar Holding Corp
W
Cheaper
vs Medical Data Vision Co Ltd
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett